Bob Burrows | VP-IR |
Bob Kramer | President and CEO |
Rich Lindahl | CFO |
Doug White | SVP, Devices Business Unit Head |
Brandon Folkes | Cantor Fitzgerald |
Jessica Fye | JPMorgan |
David Maris | Wells Fargo |
Keay Nakae | Chardan |
Lisa Springer | Singular Research |
John Scott | Cowen |
Good day, ladies and gentlemen, and welcome to the Emergent BioSolutions Second Quarter 2019 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded.
I would now like to turn the conference over to your host, Mr. Bob Burrows, Vice President, Investor Relations. Sir, you may begin.